查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
亚太地区肉毒桿菌毒素市场预测至 2031 年 - 区域分析 - 按产品（肉毒桿菌毒素 A 和肉毒毒素 B）、应用（医疗和美容）和最终用户（专科和皮肤科诊所、医院和诊所等）
市场调查报告书
商品编码
1592655

亚太地区肉毒桿菌毒素市场预测至 2031 年 - 区域分析 - 按产品（肉毒桿菌毒素 A 和肉毒毒素 B）、应用（医疗和美容）和最终用户（专科和皮肤科诊所、医院和诊所等）

Asia Pacific Botulinum Toxin Market Forecast to 2031 - Regional Analysis - by Product (Botulinum Toxin A and Botulinum Toxin B), Application (Medical and Aesthetic), and End User (Specialty & Dermatology Clinics, Hospitals & Clinics, and Others)
出版日期: | 出版商: The Insight Partners | 英文 81 Pages | 订单完成后即时交付

价格

2023年亚太肉毒桿菌毒素市场估值为9.2529亿美元，预计2031年将达27.4318亿美元；预计2023年至2031年复合年增长率为14.6%。

越来越多地使用肉毒桿菌毒素来增强脸部美观，推动亚太地区肉毒桿菌毒素市场的发展

整容手术和注射肉毒桿菌是最受欢迎的非侵入性年轻化手术之一。据 ISAPS 称，2020 年，肉毒桿菌毒素治疗是全球领先的非侵入性美容手术。此外，使用A型肉毒桿菌毒素（BoNTA）进行脸部美容治疗，以改善上下脸的美观。在过去的十年中，脸部年轻化手术比不同类型的传统手术更受欢迎。根据 ISAPS 的数据，2020 年全球进行了约 730 万例肉毒桿菌手术。

亚太地区肉毒桿菌毒素市场概况

亚太地区肉毒桿菌毒素市场分为中国、印度、日本、韩国、澳洲和亚太其他地区。患有头痛或偏头痛的人数每年都在增加，肉毒桿菌毒素已被证明可以有效降低慢性偏头痛患者头痛的频率和严重程度。此外，人们对美容手术（例如嫩肤以提高美学吸引力）的认识不断提高，以及医疗保健支出的增加，有助于推动该地区肉毒桿菌毒素市场的成长。日本的美容产业在过去经历了巨大的成长。该行业十分发达，可以接触到各种各样的美容产品。该行业受到严格监管，因此只有持有执照的医生才能进行美容手术。该国市场的主要推动力是越来越多的消费者愿意投资改变和维护自己的外表。根据 ISAPS 的数据，2021 年，全国共进行了 458,749 例肉毒桿菌手术。该国在全球进行非手术美容手术的国家中排名第三，占全球进行的手术总数的6.3%。

多家国际公司的治疗肌肉痉挛的产品已获得批准。因此，日本企业采取了策略性措施来确保自己的市场地位。 2021 年 6 月，帝人製药有限公司和 Merz 集团旗下企业 Merz Therapeutics 共同宣布，帝人製药已获得日本厚生劳动省 (MHLW) 的额外批准，可销售 Xeomin（incobotulinumtoxinA）。为了治疗下肢痉挛，Xeomin将以50、100或200单位的肌肉注射形式使用。这项策略性倡议使两家公司都受益，因为 Xeomin 在日本成功推出了治疗痉挛的药物。因此，此类事件预计将鼓励更多企业开发针对不同医疗状况的肉毒桿菌进入日本市场。

亚太地区肉毒桿菌毒素市场收入及 2031 年预测（百万美元）

亚太地区肉毒毒素市场区隔

亚太地区肉毒桿菌毒素市场按产品、应用、最终用户和国家分类。

根据产品，亚太肉毒桿菌毒素市场分为A型肉毒桿菌毒素和B型肉毒桿菌毒素。 。

在应用方面，亚太肉毒桿菌毒素市场分为医疗和美容。 2023年，医疗领域在亚太肉毒桿菌毒素市场中占据较大份额。此外，美观部分也细分为皱眉纹/眉间纹、额头纹、鱼尾纹、方下巴/咬肌等。

依最终用户划分，亚太地区肉毒桿菌毒素市场分为专科和皮肤科诊所、医院和诊所等。 2023年，专科诊所和皮肤科诊所占据亚太地区肉毒桿菌市场的最大份额。

依国家/地区划分，亚太地区肉毒桿菌市场分为日本、中国、印度、韩国、澳洲和亚太地区其他地区。 2023年，日本在亚太地区肉毒桿菌素市场占有率中占据主导地位。

Merz Pharma GmbH & Co KGaA、AbbVie Inc、Ipsen SA、Evolus Inc、Meditox Inc、Galderma SA、Hugel Inc 和兰州生物製品研究所有限公司是亚太肉毒桿菌毒素市场上的一些领先公司。

目录

第 1 章：简介

第 2 章：执行摘要

  • 主要见解

第 3 章：研究方法

  • 覆盖范围
  • 二次研究
  • 初步研究

第 4 章：亚太地区肉毒桿菌毒素市场 - 主要市场动态

  • 市场驱动因素
    • 非侵入性美容手术日益普及
    • 增加肉毒桿菌毒素的使用以增强脸部美观
  • 市场限制
    • 肉毒桿菌毒素的副作用
  • 市场机会
    • 新兴经济体越来越多地采用美容手术
  • 未来趋势
    • 扩大治疗应用
  • 驱动因素和限制的影响：

第 5 章：肉毒桿菌市场 - 亚太地区分析

  • 概述
  • 肉毒桿菌市场收入，2021-2031

第 6 章：亚太地区肉毒桿菌毒素市场分析 - 按产品

  • 概述
  • A型肉毒桿菌毒素
  • 肉毒桿菌B

第 7 章：亚太地区肉毒桿菌毒素市场分析 - 按应用

  • 概述
  • 医疗的
  • 美学的

第 8 章：亚太地区肉毒桿菌毒素市场分析 - 按最终用户

  • 概述
  • 专科和皮肤科诊所
  • 医院和诊所
  • 其他的

第 9 章：亚太地区肉毒桿菌毒素市场 - 国家分析

  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 韩国
    • 澳洲
    • 亚太地区其他地区

第 10 章：公司简介

  • Merz Pharma GmbH & Co KGaA
  • AbbVie Inc
  • Ipsen SA
  • Evolus Inc
  • Medytox Inc
  • Galderma SA
  • Hugel Inc
  • Lanzhou Institute of Biological Products Co Ltd

第 11 章：附录

Product Code: TIPRE00028639

The Asia Pacific botulinum toxin market was valued at US$ 925.29 million in 2023 and is expected to reach US$ 2,743.18 million by 2031; it is estimated to register a CAGR of 14.6% from 2023 to 2031.

Increasing Use of Botulinum Toxin for Enhancing Facial Aesthetics Boosts Asia Pacific Botulinum Toxin Market

Cosmetic surgery and injectable botulinum toxin are among the most popular noninvasive rejuvenation procedures. According to the ISAPS, in 2020, the botulinum toxin treatment was the leading noninvasive cosmetic procedure performed worldwide. Moreover, the use of botulinum toxin type A-based (BoNTA) cosmetic facial treatments are performed to improve the aesthetics of the upper and lower face. In the last decade, a facial rejuvenation procedure has gained significant popularity over different types of traditional surgeries. According to the ISAPS, ~7.3 million botulinum toxin procedures were performed globally in 2020. Thus, the surge in the adoption of botulinum toxin in facial aesthetic procedures for both men and women from all age groups is driving the botulinum toxin market growth.

Asia Pacific Botulinum Toxin Market Overview

The Asia Pacific botulinum toxin market is segmented into China, India, Japan, South Korea, Australia, and the Rest of Asia Pacific. The number of people suffering from headache or migraine has been rising every year, and botulinum toxin has been proven effective in reducing the frequency and severity of headaches in patients with chronic migraine. Moreover, the rising awareness of cosmetic procedures such as skin rejuvenation to improve aesthetic appeal and an increase in healthcare expenditure help to boost the growth of the botulinum toxin market in the region. The aesthetic industry in Japan has witnessed massive growth in the past. The industry is well-developed and has access to a wide range of aesthetic products. The industry is highly regulated, and hence, only licensed medical doctors perform aesthetic procedures. The market in the country is mainly driven by the increasing number of consumers willing to invest in altering and maintaining their looks. According to the ISAPS, in 2021, 458,749 botulinum toxin procedures were performed across the country. The country ranks 3rd among all the countries performing nonsurgical aesthetic procedures in the world, with share of 6.3% of the total procedures performed in the world.

Various international companies have obtained approvals for their products that treat muscle spasticity. Thus, Japanese firms have taken strategic initiatives to secure their positions in the market. In June 2021, Teijin Pharma Limited and Merz Therapeutics, a business of the Merz Group, together announced that Teijin Pharma had been granted additional approval by Japan's Ministry of Health, Labor and Welfare (MHLW) to market Xeomin (incobotulinumtoxinA). To treat lower limb spasticity, Xeomin would be used in the form of intramuscular injection in 50, 100, or 200 units. This strategic move has benefited both companies for the successful launch of Xeomin to treat spasticity indication in Japan. Thus, such instances are expected to encourage more players to develop botulinum toxin for different medical conditions to enter the Japanese market.

Asia Pacific Botulinum Toxin Market Revenue and Forecast to 2031 (US$ Million)

Asia Pacific Botulinum Toxin Market Segmentation

The Asia Pacific botulinum toxin market is categorized into product, application, end user, and country.

Based on product, the Asia Pacific botulinum toxin market is bifurcated into botulinum toxin A and botulinum toxin B. The botulinum toxin A segment held a larger share of Asia Pacific botulinum toxin market share in 2023.

In terms of application, the Asia Pacific botulinum toxin market is bifurcated into medical and aesthetic. The medical segment held a larger share of Asia Pacific botulinum toxin market in 2023. Furthermore, the medical segment is subcategorized into chronic migraine, muscle spasm, over reactive bladder, hyperhidrosis, and others. Additionally, the aesthetic segment is subcategorized into frown lines/ glabellar, forehead lines, crow's feet, square jaw/ masseter, and others.

By end user, the Asia Pacific botulinum toxin market is divided into specialty & dermatology clinics, hospitals & clinics, and others. The specialty and dermatology clinics segment held the largest share of Asia Pacific botulinum toxin market in 2023.

Based on country, the Asia Pacific botulinum toxin market is segmented into Japan, China, India, South Korea, Australia, and the Rest of Asia Pacific. Japan dominated the Asia Pacific botulinum toxin market share in 2023.

Merz Pharma GmbH & Co KGaA, AbbVie Inc, Ipsen SA, Evolus Inc, Medytox Inc, Galderma SA, Hugel Inc, and Lanzhou Institute of Biological Products Co Ltd are some of the leading companies operating in the Asia Pacific botulinum toxin market.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Asia Pacific Botulinum Toxin Market - Key Market Dynamics

  • 4.1 Market Drivers
    • 4.1.1 Rising Popularity of Noninvasive Aesthetics Procedures
    • 4.1.2 Increasing Use of Botulinum Toxin for Enhancing Facial Aesthetics
  • 4.2 Market Restraints
    • 4.2.1 Side Effects of Botulinum Toxin
  • 4.3 Market Opportunities
    • 4.3.1 Rising Adoption of Aesthetic Procedure in Emerging Economies
  • 4.4 Future Trends
    • 4.4.1 Expanding Therapeutic Applications
  • 4.5 Impact of Drivers and Restraints:

5. Botulinum Toxin Market - Asia Pacific Analysis

  • 5.1 Overview
  • 5.2 Botulinum Toxin Market Revenue (US$ Million), 2021-2031

6. Asia Pacific Botulinum Toxin Market Analysis - by Product

  • 6.1 Overview
  • 6.2 Botulinum Toxin A
    • 6.2.1 Overview
    • 6.2.2 Botulinum Toxin A: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million)
  • 6.3 Botulinum Toxin B
    • 6.3.1 Overview
    • 6.3.2 Botulinum Toxin B: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million)

7. Asia Pacific Botulinum Toxin Market Analysis - by Application

  • 7.1 Overview
  • 7.2 Medical
    • 7.2.1 Overview
    • 7.2.2 Medical: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million)
      • 7.2.2.1 Asia Pacific Botulinum Toxin Market Breakdown, by Medical
  • 7.3 Aesthetic
    • 7.3.1 Overview
    • 7.3.2 Aesthetic: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million)
      • 7.3.2.1 Asia Pacific Botulinum Toxin Market Breakdown, by Aesthetic

8. Asia Pacific Botulinum Toxin Market Analysis - by End User

  • 8.1 Overview
  • 8.2 Specialty and Dermatology Clinics
    • 8.2.1 Overview
    • 8.2.2 Specialty and Dermatology Clinics: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million)
  • 8.3 Hospitals and Clinics
    • 8.3.1 Overview
    • 8.3.2 Hospitals and Clinics: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million)
  • 8.4 Others
    • 8.4.1 Overview
    • 8.4.2 Others: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million)

9. Asia Pacific Botulinum Toxin Market - Country Analysis

  • 9.1 Asia Pacific: Botulinum Toxin Market
    • 9.1.1 Asia Pacific: Botulinum Toxin Market - Revenue and Forecast Analysis - by Country
      • 9.1.1.1 Japan
        • 9.1.1.1.1 Overview
        • 9.1.1.1.2 Japan: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million)
        • 9.1.1.1.3 Japan: Botulinum Toxin Market Breakdown, by Product
        • 9.1.1.1.4 Japan: Botulinum Toxin Market Breakdown, by Application
        • 9.1.1.1.4.1 Japan: Botulinum Toxin Market Breakdown, by Medical
        • 9.1.1.1.4.2 Japan: Botulinum Toxin Market Breakdown, by Aesthetic
        • 9.1.1.1.5 Japan: Botulinum Toxin Market Breakdown, by End User
      • 9.1.1.2 China
        • 9.1.1.2.1 Overview
        • 9.1.1.2.2 China: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million)
        • 9.1.1.2.3 China: Botulinum Toxin Market Breakdown, by Product
        • 9.1.1.2.4 China: Botulinum Toxin Market Breakdown, by Application
        • 9.1.1.2.4.1 China: Botulinum Toxin Market Breakdown, by Medical
        • 9.1.1.2.4.2 China: Botulinum Toxin Market Breakdown, by Aesthetic
        • 9.1.1.2.5 China: Botulinum Toxin Market Breakdown, by End User
      • 9.1.1.3 India: Botulinum Toxin Market - Revenue and Forecast to 2030 (US$ Million)
        • 9.1.1.3.1 Overview
        • 9.1.1.3.2 India: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million)
        • 9.1.1.3.3 India: Botulinum Toxin Market Breakdown, by Product
        • 9.1.1.3.4 India: Botulinum Toxin Market Breakdown, by Application
        • 9.1.1.3.4.1 India: Botulinum Toxin Market Breakdown, by Medical
        • 9.1.1.3.4.2 India: Botulinum Toxin Market Breakdown, by Aesthetic
        • 9.1.1.3.5 India: Botulinum Toxin Market Breakdown, by End User
      • 9.1.1.4 South Korea
        • 9.1.1.4.1 Overview
        • 9.1.1.4.2 South Korea: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million)
        • 9.1.1.4.3 South Korea: Botulinum Toxin Market Breakdown, by Product
        • 9.1.1.4.4 South Korea: Botulinum Toxin Market Breakdown, by Application
        • 9.1.1.4.4.1 South Korea: Botulinum Toxin Market Breakdown, by Medical
        • 9.1.1.4.4.2 South Korea: Botulinum Toxin Market Breakdown, by Aesthetic
        • 9.1.1.4.5 South Korea: Botulinum Toxin Market Breakdown, by End User
      • 9.1.1.5 Australia
        • 9.1.1.5.1 Overview
        • 9.1.1.5.2 Australia: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million)
        • 9.1.1.5.3 Australia: Botulinum Toxin Market Breakdown, by Product
        • 9.1.1.5.4 Australia: Botulinum Toxin Market Breakdown, by Application
        • 9.1.1.5.4.1 Australia: Botulinum Toxin Market Breakdown, by Medical
        • 9.1.1.5.4.2 Australia: Botulinum Toxin Market Breakdown, by Aesthetic
        • 9.1.1.5.5 Australia: Botulinum Toxin Market Breakdown, by End User
      • 9.1.1.6 Rest of Asia Pacific
        • 9.1.1.6.1 Overview
        • 9.1.1.6.2 Rest of Asia Pacific: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million)
        • 9.1.1.6.3 Rest of Asia Pacific: Botulinum Toxin Market Breakdown, by Product
        • 9.1.1.6.4 Rest of Asia Pacific: Botulinum Toxin Market Breakdown, by Application
        • 9.1.1.6.4.1 Rest of Asia Pacific: Botulinum Toxin Market Breakdown, by Medical
        • 9.1.1.6.4.2 Rest of Asia Pacific: Botulinum Toxin Market Breakdown, by Aesthetic
        • 9.1.1.6.5 Rest of Asia Pacific: Botulinum Toxin Market Breakdown, by End User

10. Company Profiles

  • 10.1 Merz Pharma GmbH & Co KGaA
    • 10.1.1 Key Facts
    • 10.1.2 Business Description
    • 10.1.3 Products and Services
    • 10.1.4 Financial Overview
    • 10.1.5 SWOT Analysis
    • 10.1.6 Key Developments
  • 10.2 AbbVie Inc
    • 10.2.1 Key Facts
    • 10.2.2 Business Description
    • 10.2.3 Products and Services
    • 10.2.4 Financial Overview
    • 10.2.5 SWOT Analysis
    • 10.2.6 Key Developments
  • 10.3 Ipsen SA
    • 10.3.1 Key Facts
    • 10.3.2 Business Description
    • 10.3.3 Products and Services
    • 10.3.4 Financial Overview
    • 10.3.5 SWOT Analysis
    • 10.3.6 Key Developments
  • 10.4 Evolus Inc
    • 10.4.1 Key Facts
    • 10.4.2 Business Description
    • 10.4.3 Products and Services
    • 10.4.4 Financial Overview
    • 10.4.5 SWOT Analysis
    • 10.4.6 Key Developments
  • 10.5 Medytox Inc
    • 10.5.1 Key Facts
    • 10.5.2 Business Description
    • 10.5.3 Products and Services
    • 10.5.4 Financial Overview
    • 10.5.5 SWOT Analysis
    • 10.5.6 Key Developments
  • 10.6 Galderma SA
    • 10.6.1 Key Facts
    • 10.6.2 Business Description
    • 10.6.3 Products and Services
    • 10.6.4 Financial Overview
    • 10.6.5 SWOT Analysis
    • 10.6.6 Key Developments
  • 10.7 Hugel Inc
    • 10.7.1 Key Facts
    • 10.7.2 Business Description
    • 10.7.3 Products and Services
    • 10.7.4 Financial Overview
    • 10.7.5 SWOT Analysis
    • 10.7.6 Key Developments
  • 10.8 Lanzhou Institute of Biological Products Co Ltd
    • 10.8.1 Key Facts
    • 10.8.2 Business Description
    • 10.8.3 Products and Services
    • 10.8.4 Financial Overview
    • 10.8.5 SWOT Analysis
    • 10.8.6 Key Developments

11. Appendix

  • 11.1 About The Insight Partners
  • 11.2 Glossary of Terms

List Of Tables

  • Table 1. Botulinum Toxin Market Segmentation
  • Table 2. Asia Pacific Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million) - by Medical
  • Table 3. Asia Pacific Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million) - by Aesthetic
  • Table 4. Japan: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million) - by Product
  • Table 5. Japan: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million) - by Application
  • Table 6. Japan: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million) - by Medical
  • Table 7. Japan: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million) - by Aesthetic
  • Table 8. Japan: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million) - by End User
  • Table 9. China: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million) - by Product
  • Table 10. China: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million) - by Application
  • Table 11. China: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million) - by Medical
  • Table 12. China: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million) - by Aesthetic
  • Table 13. China: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million) - by End User
  • Table 14. India: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million) - by Product
  • Table 15. India: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million) - by Application
  • Table 16. India: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million) - by Medical
  • Table 17. India: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million) - by Aesthetic
  • Table 18. India: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million) - by End User
  • Table 19. South Korea: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million) - by Product
  • Table 20. South Korea: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million) - by Application
  • Table 21. South Korea: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million) - by Medical
  • Table 22. South Korea: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million) - by Aesthetic
  • Table 23. South Korea: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million) - by End User
  • Table 24. Australia: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million) - by Product
  • Table 25. Australia: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million) - by Application
  • Table 26. Australia: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million) - by Medical
  • Table 27. Australia: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million) - by Aesthetic
  • Table 28. Australia: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million) - by End User
  • Table 29. Rest of Asia Pacific: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million) - by Product
  • Table 30. Rest of Asia Pacific: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million) - by Application
  • Table 31. Rest of Asia Pacific: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million) - by Medical
  • Table 32. Rest of Asia Pacific: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million) - by Aesthetic
  • Table 33. Rest of Asia Pacific: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million) - by End User
  • Table 34. Glossary of Terms

List Of Figures

  • Figure 1. Botulinum Toxin Market Segmentation, by Country
  • Figure 2. Botulinum Toxin Market - Key Market Dynamics
  • Figure 3. Impact Analysis of Drivers and Restraints
  • Figure 4. Botulinum Toxin Market Revenue (US$ Million), 2021-2031
  • Figure 5. Botulinum Toxin Market Share (%) - by Product (2023 and 2031)
  • Figure 6. Botulinum Toxin A: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 7. Botulinum Toxin B: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 8. Botulinum Toxin Market Share (%) - by Application (2023 and 2031)
  • Figure 9. Medical: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 10. Aesthetic: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 11. Botulinum Toxin Market Share (%) - by End User (2023 and 2031)
  • Figure 12. Specialty and Dermatology Clinics: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 13. Hospitals and Clinics: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 14. Others: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 15. Asia Pacific: Botulinum Toxin Market, by Key Country - Revenue (2023) (US$ Million)
  • Figure 16. Asia Pacific: Botulinum Toxin Market Breakdown, by Key Countries, 2023 and 2031 (%)
  • Figure 17. Japan: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 18. China: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 19. India: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 20. South Korea: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 21. Australia: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 22. Rest of Asia Pacific: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million)